When even the CEO's at Lilly will whitewash the truth, then how can the general public trust any of their drugs.

From SSRI Stories:

http://www.ssristories.com/show.php?item=1779

Paragraph 18 reads: "Just seven months into his tenure at Lilly, his first wife, Marilyn, committed suicide. He later spoke candidly about her death and the fact that Lilly's blockbuster antidepressant, Prozac, couldn't help her."

http://www.indystar.com/apps/pbcs.dll/article?AID=/20070513/LOCAL/705130417/-1/LOCAL17

IndyStar.com Metro & State

May 13, 2007

Tobias will be back, say friends
Ex-Lilly CEO named in D.C. sex scandal issues a statement about his plans.

Randall Tobias said Saturday that he and his wife will spend most of their time in Indy.

By Ken Kusmer
Associated Press

In his 2003 book on leadership, Randall Tobias likened difficult or unpleasant issues to a moose in the room. It's better to address the issue openly and honestly, he wrote, than ignore the moose and risk negative consequences.

Randall Tobias said Saturday that he and his wife will spend most of their time in Indy.

Here is another sneaky item pulled off by Lilly. They deserve to go down the tubes.

http://www.ssristories.com/show.php?item=2937

Peter R. Breggin, M.D. was the expert witness for the plaintiffs in the Joseph Wesbecker trial [while on Prozac, Wesbecker killed 8 people and seriously wounded 12 people at the Standard Gravure plant in Louisville, KY in 1989], As the expert witness, Dr. Breggin was allowed ‘discovery’, which meant that he was permitted to search through Eli Lilly’s data on their clinical trials of Prozac.

Paul Smith of Dallas, Texas was the attorney for the plaintiffs. He had agreed to “fix” the trial in Lilly’s favor before the trial began [pages 250 to 257 of “Medication Madness” by Peter R. Breggin, M.D.]

Page 252 of the book “Medication Madness” by Peter R. Breggin, M.D. reads: “Before I got on the stand, attorney Paul Smith had told me in a shouting match not to dare bring up one particular smoking gun. From my Freedom of Information Act inquiries to the FDA, I had found that initial drafts of the Prozac label had listed “depression” and “abnormal thoughts” as two of the three most commonly reported adverse reactions to the drug. In these drafts, the company in effect admitted that it own principal investigators – the scientists conducting the clinical trials- were reporting that their patients frequently became more depressed on Prozac. Combined with an increase in “abnormal thoughts” this indicated that the drug was making many people worse and even potentially dangerous. I then discovered that shortly before the label was made official, “abnormal thoughts” was dropped from the list of the top three adverse effects and replaced with the more innocuous “abnormal dreams.” Then, on the last day before the label was officially approved, an FDA official scratched out “depression” from its prominent place in the label. Depression as a serious adverse effect of Prozac went from being “frequent” to being nonexistent. The company, in combination with the FDA, had expurgated some of the most damning information from the label shortly before its publication. Attorney Paul Smith outright refused to let me testify about this.

.

Well, Eli can always raise a bit of pin money by manufacturing and selling narcotics, I suppose. It has a certain amount of experience in that field, after all.

"Operation Midnight Climax"! That's about right for a bunch of wankers!

Matt

"Depression as a serious adverse effect of Prozac went from being “frequent” to being nonexistent."

Speaking of adverse effects disappearing from labels: The Cymbalta label dated 9/2006 has many adverse reactions listed that are not listed on newer labels and nothing has increased in frequency. For example: Under "Other Adverse Reactions Observed During the Premarketing and Postmarketing Clinical Trial Evaluation of Duloxetine - Cardiac Disorders"

9/2006: Frequent: palpitations; Infrequent: atrial fibrillation, bundle branch
block right, cardiac failure, cardiac failure congestive, coronary artery disease, myocardial
infarction, and tachycardia

11/2009: Frequent: palpitations; Infrequent: myocardial infarction and tachycardia.

"Completed Suicide" was changed from "Infrequent" to "Rare". This is BEFORE you get to the "Postmarketing spontaneous reporting" section, I don't see how the data could have changed.

There are many more sections with similar changes.

Scary news!
Cymbalta for headache, back-pain, dog version for separation anxiety, and why not for gaining weight?
It's not easy to gain weight to some people.
Jesus! Now I fear they read it and take it seriously.
"Have tried all diets to gain weight? Cymbalta is the answer!"
I don't doubt!